1 Min Read
Feb 13 (Reuters) - Onxeo:
* Receives USPTO Notice Of Allowance for a new asiDNATM-related patent, expanding its IP protection in the U.S.
* This newly allowed patent will expire in mid-2031
* The term of the patent could be further extended to 2036 through patent term extension (PTE) Source text for Eikon: Further company coverage: (Gdynia Newsroom)